check_circleStudy Completed

Hypertension, Postmenopause, Hormone Replacement Therapy

Study to evaluate the effect of a preparation containing DRSP 3 mg and E2 1 mg on blood pressure in mildly hypertensive postmenopausal women

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
213
Trial Dates
July 2001 - April 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Angeliq (E2/DRSP, BAY86-4891)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

A multicenter, double-blind, randomized, placebo-controlled study to evaluate the effect of a continuous-combined HRT preparation containing DRSP 3 mg and E2 1 mg on blood pressure in mildly hypertensive postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A